Patents by Inventor Fred K. Chen

Fred K. Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Retinitis pigmentosa treatment
    Patent number: 12649922
    Abstract: An isolated or purified antisense oligomer for modifying pre-mRNA splicing in the CNOT3 gene transcript or part thereof.
    Type: Grant
    Filed: July 31, 2024
    Date of Patent: June 9, 2026
    Assignee: Vision Pharma PTY LTD
    Inventors: Sue Fletcher, Ianthe Pitout, Janya Grainok, Steve D. Wilton, Fred K. Chen
  • Retinitis pigmentosa treatment
    Patent number: 12559747
    Abstract: An isolated or purified antisense oligomer for modifying pre-mRNA splicing in the CNOT3 gene transcript or part thereof.
    Type: Grant
    Filed: May 25, 2020
    Date of Patent: February 24, 2026
    Assignee: VISION PHARMA PTY LTD
    Inventors: Sue Fletcher, Ianthe Pitout, Jayna Grainok, Steve D. Wilton, Fred K. Chen
  • Novel Retinitis Pigmentosa Treatment
    Publication number: 20250066782
    Abstract: An isolated or purified antisense oligomer for modifying pre-mRNA splicing in the CNOT3 gene transcript or part thereof.
    Type: Application
    Filed: July 31, 2024
    Publication date: February 27, 2025
    Inventors: Sue Fletcher, Ianthe Pitout, Jayna Grainok, Steve D. Wilton, Fred K. Chen
  • Novel Retinitis Pigmentosa Treatment
    Publication number: 20220298506
    Abstract: An isolated or purified antisense oligomer for modifying pre-mRNA splicing in the CNOT3 gene transcript or part thereof.
    Type: Application
    Filed: May 25, 2020
    Publication date: September 22, 2022
    Inventors: Sue Fletcher, Ianthe Pitout, Jayna Grainok, Steve D. Wilton, Fred K. Chen